Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-08T17:32:34.807Z Has data issue: false hasContentIssue false

Testosterona and suicide

Published online by Cambridge University Press:  01 September 2022

L. Gallardo Borge*
Affiliation:
Hospital San Pedro, Psychiatry, Logroño, Spain
I.D.L.M. Santos Carrasco
Affiliation:
Hospital Clínico Universitario, Psychiatry, Valladolid, Spain
P. Marqués Cabezas
Affiliation:
Hospital Clínico Universitario, Psychiatry, Valladolid, Spain
A.I. Segura Rodríguez
Affiliation:
Hospital Clínico Universitario, Psychiatry, Valladolid, Spain
G. Medina Ojeda
Affiliation:
Hospital Clínico Universitario, Psychiatry, Valladolid, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Testosterone is an anabolic androgenic steroid hormone involved in brain development, reproduction, and social behavior. Several studies have shown that testosterone can cause impulsivity in humans. This impulsivity could modify the mood and increase the risk of suicidal behaviour.

Objectives

Testosterone is an anabolic androgenic steroid hormone involved in brain development, reproduction, and social behavior. Several studies have shown that testosterone can cause impulsivity in humans. This impulsivity could modify the mood and increase the risk of suicidal behaviour.

Methods

Clinical case and literature review.

Results

A 33-years male (biological female), single, gypsy ethnicity, with an 11-years daughter. Psychiatric history of one admission in a hospitalization unit. Diagnosed of depressive disorder and personality disorder NOS. Intermittent follow-up in Mental Health consultations. 8 years later, he consulted due to gender dysphoria. He refered not to be feeling identified with his body for a long time. He rejected his sexual characteristics. After his mental evaluation, he was refered to Endocrinology Service. He had been prescribed with testosterone. Three days after starting the treatment, he maked anattempt of suicide with medication. The patient had not presented previous suicide attempts or ideation. With the withdrawal of the testosterone, the suicidal behaviour dissapeared.

Conclusions

Due to the association of testosterone and suicidal behavoiur, we consider that is important to pay attention to people who have just started the androgenic treatment in order to avoid a high risk of suicide. In the same way, we should focus on evaluating the hostility, impulsivity and irritability in patients strongly related to suicidal behaviour.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.